ロード中...
Use of Placebos in Phase 1 Preventive HIV Vaccine Clinical Trials
Phase 1 preventive HIV vaccine trials are often designed as randomized, double-blind studies with the inclusion of placebo recipients. Careful consideration is needed to determine when the inclusion of placebo recipients is highly advantageous and when it is optional for achieving the study objectiv...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554766/ https://ncbi.nlm.nih.gov/pubmed/25454855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.10.017 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|